Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray

Dr. Tony Wyss-Coray's research demonstrates that factors in young blood can rejuvenate the brain and other tissues in older individuals, with implications for predicting and reversing organ aging.

• Factors in young blood and exercise can rejuvenate aging brains and other tissues.

• New technologies can predict individual organ and cell aging, offering personalized health interventions.

• Health span, not just lifespan, is the primary goal, focusing on maintaining organ function and vitality.

Blood contains factors that actively influence the body's health and aging, not merely reflect its status. Research shows that young blood can reactivate stem cells, reduce inflammation, and improve memory function in aged mouse brains. Scientists are working to identify key beneficial factors and translate these findings into human therapies to extend health span, focusing on personalized interventions based on individual organ aging profiles.

Young Blood Rejuvenation

• 00:03:38 Dr. Tony Wyss-Coray's lab collaborates on parabiosis experiments, where the circulatory systems of young and old mice are connected, allowing young blood factors to rejuvenate old muscle stem cells and improve brain function and memory. This research aims to understand if these 'youthful' bloodborne factors can act as medicine, influencing cell and organ function and potentially reversing aging, rather than just serving as biomarkers of health status.

Human Translation & Trials

• 00:08:41 To translate findings to humans, a company named Alkahest was started, injecting human young or old blood into mouse brains, confirming similar rejuvenating effects in mice as with young mouse blood. Clinical trials were initiated in Alzheimer's and Parkinson's patients using plasma fractions from healthy donors, showing promising results in small trials and significant benefits in a 500-patient Alzheimer's study involving therapeutic plasma exchange, indicating potential for FDA-approved therapies.

Organ-Specific Aging Clocks

• 00:23:13 Organs and cells within an organism age at slightly different rates, a discovery made possible by molecular tools assessing thousands of proteins in blood to estimate specific organ ages. This 'age gap' between chronological age and an organ's estimated age is a strong predictor of future disease risk in that specific organ, such as the heart, kidney, or brain. The company Vero Biosciences aims to use this technology for early detection and tailored interventions to delay organ aging and extend health span.

Vitality vs. Longevity

• 00:38:08 The relationship between vitality and longevity is complex, with some factors like growth hormone increasing vitality but potentially decreasing lifespan, an concept known as antagonistic pleiotropy. While natural human lifespan was historically much shorter, modern medicine and hygiene have extended it, but the balance between feeling youthful and living longer remains an open question. The field needs to find interventions that promote sustained vitality rather than merely extending a period of decline.

Exercise and Fasting Effects

• 00:48:04 Research indicates that exercise in young mice releases beneficial factors, particularly from the liver, that can improve brain function when transferred to other mice, with exercise-induced young blood showing stronger effects. Specific compounds like clusterin and GLDH, as well as an amino acid conjugated to lactate (lacy), are being investigated as mediators of exercise benefits. Caloric restriction and intermittent fasting also activate diverse beneficial pathways in animal models, reducing inflammation and oxidative damage, but their consistent, tangible benefits for human lifespan or health span remain under investigation.

Cell-Specific Aging & Proteome Map

• 01:50:02 Advancements allow for estimating the age of specific cell types in the body, beyond just organs, by analyzing thousands of proteins in blood. This led to findings like an enrichment of 'extremely old' muscle cells in ALS patients, strongly predicting disease development. An ongoing effort aims to build a comprehensive map of the human proteome across thousands of monogenic diseases, profiling plasma to understand how disruptions in specific genes manifest in protein patterns, offering potential for more precise diagnostics and targeted therapies for complex diseases.